Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study)

Cancer Clinical Trial

— Quit2Heal  

Official title:

Pilot Trial of a Smartphone Smoking Cessation Application Intervention for Cancer Patients (Quit2Heal Study)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03600038
• Other study ID #: 8630
• Secondary ID: NCI-2018-02641RG
• Status: Completed
• Phase: N/A
• Start date: April 2, 2018
• Est. completion date: December 1, 2019

Study information

• Verified date: December 2019
• Source: Fred Hutchinson Cancer Research Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this study is to determine whether the novel smartphone application designed specifically for cancer patients to quit smoking (Quit2Heal) provides higher quit rates than the current standard smoking cessation app.

Description:

Cigarette smoking has harmful effects on cancer patients' treatment and prognosis, but there are systemic barriers to delivering smoking cessation interventions to cancer patients. One solution for addressing these barriers is to give patients immediate access to smoking cessation treatment via a smartphone application. The Quit2Heal smartphone app is engaging and tailored to the specific needs of cancer patients, and can be integrated into routine cancer care. The goal of this study is to determine whether Quit2Heal provides higher quit rates than the current standard smoking cessation app.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 59
• Est. completion date: December 1, 2019
• Est. primary completion date: July 31, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age 18 or older

• diagnosed with cancer in the past 12 months

• has smoked a cigarette (even a puff) in the past 30 days

• interested in learning skills to quit smoking

• willing to be randomly assigned to either smartphone application

• resides in US

• has at least daily access to their own smartphone

• knows how to login and download a smartphone application from the Apple app store or Android Play app store

• willing and able to read in English

• not currently using cessation medications or enrolled in other smoking cessation programs, and

• has never used the NCI's Quit Guide smartphone application.

• willing and able to complete one follow-up survey

• willing to provide email, phone, and mailing address.

Exclusion Criteria:

• The exclusion criteria are opposite of the inclusion criteria listed above.

Related Conditions & MeSH terms

• Cancer
• Smoking

Intervention

Behavioral:
• Experimental smoking cessation smartphone app
The experimental arm includes an intervention using a novel/experimental smartphone smoking cessation app.
• Standard of care smoking cessation smartphone app
The control intervention uses a standard of care smartphone smoking cessation app.

Locations

Country	Name	City	State
United States	Fred Hutchinson Cancer Research Center	Seattle	Washington

Sponsors (3)

Lead Sponsor	Collaborator
Fred Hutchinson Cancer Research Center	CVS Health Foundation, National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	30-day point prevalence abstinence	No smoking in the past 30 days, as reported 2 months post treatment.	2 months post randomization

External Links

•   Quit2Heal Study recruitment website